Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin

JAMA Dermatol. 2018 Jan 1;154(1):101. doi: 10.1001/jamadermatol.2017.4169.

Authors

Omeed Ahadiat^{1

2}, Shauna Higgins¹, Steve Kwon³, Ashley Wysong¹

Affiliations

¹ Department of Dermatology, Keck Medicine of the University of Southern California, Los Angeles.
² Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois.
³ Department of Surgery, Columbia University Medical Center, Herbert Irving Pavilion, New York, New York.

Abstract

This study examines the underuse of the sentinel lymph node biopsy in the management of high-risk squamous cell carcinoma.

MeSH terms

Academic Medical Centers
Aged
California
Carcinoma, Squamous Cell / pathology*
Carcinoma, Squamous Cell / surgery
Databases, Factual
Female
Humans
Incidence
Lymphadenopathy / pathology
Lymphadenopathy / surgery
Male
Middle Aged
Needs Assessment
Neoplasm Invasiveness / pathology
Neoplasm Staging
Retrospective Studies
Risk Assessment
Sentinel Lymph Node Biopsy / statistics & numerical data*
Skin Neoplasms / pathology*
Skin Neoplasms / surgery